Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis®, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.
In addition to LinkedIn, stay connected with us via the following social media channels:
- Twitter: https://twitter.com/sema4
- Facebook: https://www.facebook.com/Sema4/
- Instagram: https://www.instagram.com/sema4/
Founded date: 2017
Mentions in press and media 10
| Date | Title | Description |
| 30.07.2020 | Sema4: $121 Million Funding And Valuation Of Over $1 Billion | Sema4 — a patient-centered health intelligence company — announced that funds managed by BlackRock led its oversubscribed Series C financing of $121 million Sema4 — a patient-centered health intelligence company — announced that funds manag... |
| 30.07.2020 | Sema4 Closes $121M Series C Funding; Post-Money Valued at $1 Billion | Sema4, a Stamford, Conn.-based patient-centered health intelligence company, raised $121m in Series C financing. Funds managed by BlackRock led the round at a post-money valuation of over $1 billion. Additional new investors include Deerfie... |
| 29.07.2020 | Sema4 Closes $121 Million Series C Led by BlackRock Funds | STAMFORD, Conn.--(BUSINESS WIRE)--Sema4, a patient-centered health intelligence company, today announced that funds managed by BlackRock led its oversubscribed Series C financing of $121 million at a post-money valuation of over $1 billion.... |
| 29.07.2020 | Sema4 : Closes $121 Million Series C Led by BlackRock Funds | Sema4, a patient-centered health intelligence company, today announced that funds managed by BlackRock led its oversubscribed Series C financing of $121 million at a post-money valuation of over $1 billion. Additional new investors include ... |
| 29.07.2020 | BlackRock Leads Sema4’s $121M Series C | 21 Shares Email Facebook Twitter LinkedIn Patient-centered health intelligence company Sema4 saw its post-money valuation go above $1 billion after closing an oversubscribed $121 million Series C financing round, the company announced Wedne... |
| 01.03.2018 | Helix holds first close on a planned $200 million investment in its genetic services marketplace | Welcome to the future… where startups are willing to customize everything from a diet regimen to a workout plan, or family planning to personal fashion based on an individual’s genetic code. Angling to be the go-to marketplace for these gen... |
| 28.09.2017 | Charting the growth in the reproductive health genetic testing market | But now there has been progress in different methods of reproductive genetic testing. For instance, a recent explosion of the utilization of additional non-invasive prenatal testing (NIPT), and the continuous expansion of upstream preconcep... |
| 01.06.2017 | Sema4, a Mount Sinai spinout, launches with a focus on genomics | Pronounced “semaphore,” the company will utilize genomic and clinical data to transform overall clinical diagnostics. By combining everything from predictive modeling to open access data, it aims to be able to better treat and diagnose dise... |
| - | Charting the growth in the reproductive health genetic testing market | The reproductive genetic testing market is poised for substantial investment and growth as demand continues, reimbursement improves, and the technology expands to additional, novel applications. The market has historically been dominated by... |
| - | Sema4, a Mount Sinai spinout, launches with a focus on genomics | New York City, New York-based Mount Sinai Health System has launched a new spinout company: Sema4. The for-profit startup has been created from numerous parts of Mount Sinai’s Department of Genetics and Genomic Sciences and the Icahn Instit... |